EMGALITY

Google image searchProduct monograph

Active ingredient

galcanezumab, 100 MG/ML

DIN: 02505134

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE DOSE PRE-FILLED SYRINGE

Schedule: Prescription / Schedule D

Company: ELI LILLY CANADA INC

Date: 11-JAN-2021

ATC:

• N02 — ANALGESICS (ATC, ATC/DDD, )
• N02C — ANTIMIGRAINE PREPARATIONS (ATC, ATC/DDD)
• N02CD — Calcitonin gene-related peptide (CGRP) antagonists (ATC, ATC/DDD)
• N02CD02 — GALCANEZUMAB (ATC/DDD)

Pharmaceutical standard: MFR

External Links for Emgality

Search on Google

• Emgality side effects
• Emgality dosage
• galcanezumab side effects
• galcanezumab dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find emgality photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.